课题基金 / 基金详情

Low-Cost, Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders

Low-Cost, Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders
低成本虚拟现实系统可增加焦虑症和强迫症暴露疗法的可及性
批准号:
9789360
负责人:
Sara Seifert
金额:
$46.37万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-08 至 2021-08-31

项目摘要

项目成果

Sara Seifert的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract Minnesota HealthSolutions (MHS) in conjunction with the Mayo Clinic and Limbix proposes to develop a low- cost, virtual reality system that provides realistic and responsive exposures for childhood anxiety disorders (CAD) and obsessive compulsive disorders (OCD). Anxiety disorders are one of the most common childhood mental health diagnoses, yet as many as 70% of youth receive little or no treatment. Cognitive Behavioral Therapy (CBT) is well supported by the research as an effective treatment for anxiety disorders. A key component to successful CBT for treating anxiety disorders is the inclusion of fear provoking exposures. Virtual reality exposure therapy (VRET) has demonstrated efficacy and acceptability in the treatment of several anxiety disorders, including specific phobias, social anxiety disorder, panic disorder and agoraphobia, post- traumatic stress disorder, and obsessive-compulsive disorder and has been used effectively with children. VR creates an immersive, multimedia experience that is three-dimensional. In the past, the cost of systems has put them out of the price range of most therapists and has made them available only as in-office tool. It is hypothesized that more patients with anxiety disorders will receive effective treatment by the development of a low-cost, VR system to provide exposure therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PA22176, SBIR Phase I, Novel Automated Screening Approach for Identifying Fall Risk
Technology-based training to improve learning-to-drive outcomes for autistic persons
A Novel Distracted Driving Prevention Tool
Sensor Network with Active Instructional Content to Prevent Child Safety Seat Misuse
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: